injectable ghk-cu clinical trial Copper Peptide Injections: Advanced Skin Rejuvenation GHK-Cu Injectable - Team Wellcore

BPC-157 / TB-500 Mix is a research-grade combination peptide that pairs two of the most extensively studied compounds in tissue repair research within a single vial 10mg of Body Protection Compound-157 and 10mg of Thymosin Beta-4 Fragment 17-23. The combination provides researchers with a single reagent for investigating complementary repair pathways, including angiogenesis-associated signalling, cellular migration, and extracellular matrix remodelling

Last reviewed: October 2025

Better for your health and nature

Rapid & Secure Express Delivery Ensuring Swift Dispatch & Secure Packaging

For research applications, systemic distribution occurs regardless of administration route, making oral dosing highly effective.Research Use Only: Not for human or veterinary therapeutic applications

Experimental aspect of BPC-157 action on the nervous system Study 1 Material The study was conducted on rats using the cuprizone toxin, which allows the achievement of disease symptoms similar to those occurring in multiple sclerosis or schizophrenia. Course of the study The BPC-157 peptide was administered to rats in drinking water or by injections, combined with the cuprizone toxin. Result Oral intake of BPC-157, approximately 10 g/kg (0.16 g/ml in water), shows effective action similar to injectable administration at doses of 10 ng/kg and 10 g/kg